Ganesamoorthy Subbanagounder - Publications

Affiliations: 
Chemistry Case Western Reserve University, Cleveland Heights, OH, United States 

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Chang MK, Binder CJ, Miller YI, Subbanagounder G, Silverman GJ, Berliner JA, Witztum JL. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. The Journal of Experimental Medicine. 200: 1359-70. PMID 15583011 DOI: 10.1084/jem.20031763  0.44
2004 Chatterjee S, Berliner JA, Subbanagounder GG, Bhunia AK, Koh S. Identification of a biologically active component in minimally oxidized low density lipoprotein (MM-LDL) responsible for aortic smooth muscle cell proliferation. Glycoconjugate Journal. 20: 331-8. PMID 15229397 DOI: 10.1023/B:GLYC.0000033629.54962.68  0.44
2003 Cole AL, Subbanagounder G, Mukhopadhyay S, Berliner JA, Vora DK. Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1384-90. PMID 12805072 DOI: 10.1161/01.ATV.0000081215.45714.71  0.44
2003 Walton KA, Cole AL, Yeh M, Subbanagounder G, Krutzik SR, Modlin RL, Lucas RM, Nakai J, Smart EJ, Vora DK, Berliner JA. Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1197-203. PMID 12775576 DOI: 10.1161/01.ATV.0000079340.80744.B8  0.44
2003 Jung ME, Kers A, Subbanagounder G, Berliner JA. Studies towards the total synthesis of an epoxy isoprostane phospholipid, a potent activator of endothelial cells. Chemical Communications (Cambridge, England). 196-7. PMID 12585388 DOI: 10.1039/b209892j  0.44
2002 Subbanagounder G, Deng Y, Borromeo C, Dooley AN, Berliner JA, Salomon RG. Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells. Vascular Pharmacology. 38: 201-9. PMID 12449016 DOI: 10.1016/S1537-1891(02)00170-2  0.44
2002 Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, Curtiss LK, Berliner JA, Boisvert WA. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circulation Research. 90: 1064-71. PMID 12039795 DOI: 10.1161/01.RES.0000018941.10726.FA  0.44
2002 Forte TM, Subbanagounder G, Berliner JA, Blanche PJ, Clermont AO, Jia Z, Oda MN, Krauss RM, Bielicki JK. Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice. Journal of Lipid Research. 43: 477-85. PMID 11893784  0.44
2002 Subbanagounder G, Wong JW, Lee H, Faull KF, Miller E, Witztum JL, Berliner JA. Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta. The Journal of Biological Chemistry. 277: 7271-81. PMID 11751881 DOI: 10.1074/jbc.M107602200  0.44
2001 Berliner JA, Subbanagounder G, Leitinger N, Watson AD, Vora D. Evidence for a role of phospholipid oxidation products in atherogenesis. Trends in Cardiovascular Medicine. 11: 142-7. PMID 11686004 DOI: 10.1016/S1050-1738(01)00098-6  0.44
2001 Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, Castellani LW, Reddy S, Shih D, Shi W, Watson AD, Van Lenten BJ, Vora D, Fogelman AM. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arteriosclerosis, Thrombosis, and Vascular Biology. 21: 481-8. PMID 11304461 DOI: 10.1161/01.ATV.21.4.481  0.44
2000 Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 2248-54. PMID 11031211 DOI: 10.1161/01.ATV.20.10.2248  0.44
2000 Lee H, Shi W, Tontonoz P, Wang S, Subbanagounder G, Hedrick CC, Hama S, Borromeo C, Evans RM, Berliner JA, Nagy L. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circulation Research. 87: 516-21. PMID 10988245  0.44
2000 Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, Subbanagounder G, Faull KF, Reddy ST, Miller NE, Fogelman AM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. Journal of Lipid Research. 41: 1481-94. PMID 10974056  0.44
2000 Subbanagounder G, Watson AD, Berliner JA. Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities. Free Radical Biology & Medicine. 28: 1751-61. PMID 10946217 DOI: 10.1016/S0891-5849(00)00233-1  0.44
2000 Shih DM, Xia YR, Wang XP, Miller E, Castellani LW, Subbanagounder G, Cheroutre H, Faull KF, Berliner JA, Witztum JL, Lusis AJ. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis Journal of Biological Chemistry. 275: 17527-17535. PMID 10748217 DOI: 10.1074/jbc.M910376199  0.44
1999 Leitinger N, Tyner TR, Oslund L, Rizza C, Subbanagounder G, Lee H, Shih PT, Mackman N, Tigyi G, Territo MC, Berliner JA, Vora DK. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils Proceedings of the National Academy of Sciences of the United States of America. 96: 12010-12015. PMID 10518567 DOI: 10.1073/pnas.96.21.12010  0.44
1999 Watson AD, Subbanagounder G, Welsbie DS, Faull KF, Navab M, Jung ME, Fogelman AM, Berliner JA. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein. The Journal of Biological Chemistry. 274: 24787-98. PMID 10455151 DOI: 10.1074/jbc.274.35.24787  0.44
1999 Subbanagounder G, Leitinger N, Shih PT, Faull KF, Berliner JA. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: In vitro and in vivo inhibition by WEB 2086 Circulation Research. 85: 311-318. PMID 10455059  0.44
1999 Salomon RG, Sha W, Brame C, Kaur K, Subbanagounder G, O'Neil J, Hoff HF, Roberts LJ. Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein. The Journal of Biological Chemistry. 274: 20271-80. PMID 10400646 DOI: 10.1074/jbc.274.29.20271  0.44
1999 Hörkkö S, Bird DA, Miller E, Itabe H, Leitinger N, Subbanagounder G, Berliner JA, Friedman P, Dennis EA, Curtiss LK, Palinski W, Witztum JL. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. The Journal of Clinical Investigation. 103: 117-28. PMID 9884341 DOI: 10.1172/JCI4533  0.44
1997 Salomon RG, Subbanagounder G, Singh U, O'Neil J, Hoff HF. Oxidation of low-density lipoproteins produces levuglandin-protein adducts Chemical Research in Toxicology. 10: 750-759. PMID 9250408 DOI: 10.1021/tx970016b  0.44
1997 Salomon RG, Subbanagounder G, O'Neil J, Kaur K, Smith MA, Hoff HF, Perry G, Monnier VM. Levuglandin E2 - Protein adducts in human plasma and vasculature Chemical Research in Toxicology. 10: 536-545. PMID 9168251 DOI: 10.1021/tx960157y  0.44
1997 Watson AD, Leitinger N, Navab M, Faull KF, Hörkkö S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. The Journal of Biological Chemistry. 272: 13597-607. PMID 9153208 DOI: 10.1074/jbc.272.21.13597  0.44
1997 Hoppe G, Subbanagounder G, O'Neil J, Salomon RG, Hoff HF. Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid Biochimica Et Biophysica Acta - Lipids and Lipid Metabolism. 1344: 1-5. PMID 9022751 DOI: 10.1016/S0005-2760(96)00160-9  0.44
1996 Sayre LM, Sha W, Xu G, Kaur K, Nadkarni D, Subbanagounder G, Salomon RG. Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal. Chemical Research in Toxicology. 9: 1194-201. PMID 8902276 DOI: 10.1021/tx960094j  0.44
1995 DiFranco E, Subbanagounder G, Kim S, Murthi K, Taneda S, Monnier VM, Salomon RG. Formation and stability of pyrrole adducts in the reaction of Levuglandin E2 with proteins Chemical Research in Toxicology. 8: 61-67. PMID 7703368  0.44
Show low-probability matches.